Circulating immune complexes and complement (C3) in a course of pulmonary tuberculosis;Kra̧ża̧ce kompleksy immunologiczne i układ dopełniacza (C3) w przebiegu gruźlicy płuc

Polski Merkuriusz Lekarski

Volumn 12, Issue 72, 2002, Pages 491-495

  Dubaniewicz, Anna ^a   Sztaba Kania, Magdalena ^a  

^a Kat/Zakład Fizjopatologii AM ^*  (Poland)

Author keywords

C3 complement; EA and EAC circulating immune complexes; Tuberculosis

Indexed keywords

COMPLEMENT COMPONENT C3; TUBERCULOSTATIC AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; ROSETTE FORMATION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; COMPLEMENT C3; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 0036300462     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Activation of peripheral blood neutrophils from patients with activation advanced tuberculosis
2. Inhibition of Fc-rosette formation by serum of patients with renal allograft rejection
3. Antibody-based enzyme-linked Immunosorbent Assay for determination of immune complexes in clinical tuberculosi
4. Rifampicin therapy and circulating antibodies
5. Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections
6. Cutaneous vasculitis associated with tuberculosis and its treatment
7. Rifampicin-induced acute renal failure: A series of 60 patients
8. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis
9. Immunoglobulin A nephropathy complicating pulmonary tuberculosis
10. Rifampicin-associated acute renal failure: Pathophysiologic, immunologic, and clinical features
11. Immunoprophylactic properties of 71-kDa cell wall-associated protein antigen of Mycobacterium tuberculosis H37Ra
12. Immunology of tuberculosis
13. Macrophage receptors for Mycobacterium tuberculosis
14. An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis; correction of defective neutrophil motility by ascor-bate, levamisole, metoprolol and pronalonol
15. Role of antigen specific circulating immune complexes in diagnosis of tuberculosis
16. MPB70 and MPB83 as indicators of protein localization in mycobacterial cells
17. Mycobacterium tuberculosis lipid antigens: Use of multi-antigen based enzyme immunoassay for free and complex dissociated antibodies
18. Involvement of antilipoarabinomannan antibodies in classical complement activation intuberculosis
19. Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock
20. Circulating immune complexes in tuberculosis
21. Microbial immunology: A new mechanism for immune subversion
22. Determination of red blood cell immune functions in ptients with pulmonary tuberculosis
23. The purification and identification of circulating immune complexes in tuberculosis
24. Rifampicin-induced immune thrombocytopenia
25. Crescentic glomerulo-nephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis
26. T cell response in acquired protective immunity to Mycobacterium tuberculosis infection
27. Possible role of mononuclear phagocytes in clearance of immune complexes in pulmonary tuberculsis
28. Immune complex assays: Diagnostic and clinical application
29. Diagnostic significance of circulating immune complexes in patients with pulmonary tuberculosis
30. Characterization of mycobacterial antigens and antibodies in circulating immune complexes from pulmonary tuberculosis
31. Complement activation in pulmonary tuberculosis
32. Tuberculous lymphadenitis presenting with cutaneous leucocyt-toclastic vasculitis
33. Significance of circulating immune complexes in pulmonary tuberculosis
34. The EA-rosette inhibition assay as a test for immune complexes
35. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocytes complement receptors
36. The host immune response to tuberculosis
37. A macrophage invasion mechanism of pathogenic mycobacteria
38. Immune complex nephritis complicating miliary tuberculosis
39. Circulating immune complexes in human tuberculosis sera: Demonstration of specific antibodies against Mycobacterium tuberculosis glycolipd (DAT
40. A study of the material inhibiting EAC-rosette formation in the sera of patients with nephropathies
41. Rapidly progresive glomerulonephritis and pulmonary tuberculosis
42. Kinetics of circulating antibodies, immune complexes and specific antibody-secreting cells in tuberculosis patients during 6 months antimicrobial therapy
43. Detection of mycobacterial antigen in circulating immune complexes in patients with childhood tuberculosis
44. Immune complexes in human diseases
45. Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38 kDa antigen in pulmonary tuberculosis
46. 3rd stationary phase-associated protein expression in Mycobacterium tuberculosis: Function of the mycobacterial alpha-crystallin hemolog
47. Characterization of prominent protein antigens from mycobacteria